# Phase 2 osteoarthritis trials recruiting: 31 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 31 trials in phase 2 for osteoarthritis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 osteoarthritis trials: 31 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/osteoarthritis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 31
- Recruiting or not yet: 31
- Read on: November 19, 2026

## Trials

The 25 newest of 31, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 31, 2026 | NCT07795060 | Ondansetron to Prevent Oral Rehydration Failure in Children With Cholera | Public Interest Science Center | Phase 2 | Not yet recruiting | Cholera (Disorder) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795060) |
| June 25, 2026 | NCT07668674 | Functional Brain MRI to Understand Pain Phenotypes in Knee Osteoarthritis | University Hospital, Clermont-Ferrand | Phase 2 | Not yet recruiting | Gonarthrosis, Neuropathic Pain, Nociceptive Pain | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07668674) |
| June 16, 2026 | NCT07649291 | Duloxetine and aeRobic Exercise to Improve Function in VEterans With Knee Osteoarthritis (DRIVE) | VA Office of Research and Development | Phase 2 | Not yet recruiting | Knee Osteoarthritis, Pain, Depression | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07649291) |
| June 11, 2026 | NCT07641517 | A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain | Eli Lilly and Company | Phase 2 | Recruiting | Osteoarthritis, Knee, Chronic Pain | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07641517) |
| May 12, 2026 | NCT07580716 | Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis | Enlivex Therapeutics Ltd. | Phase 2 | Recruiting | Primary Knee Osteoarthritis | 182 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07580716) |
| April 23, 2026 | NCT07547735 | Phase II Clinical Trial of UC-MSCs in the Treatment of Knee Osteoarthritis | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 | Recruiting | Knee Osteoarthritis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07547735) |
| December 29, 2025 | NCT07308470 | Etodolac Nanogel as an Adjunct to Physiotherapy for Knee Osteoarthritis | Pharos University in Alexandria | Phase 2 | Not yet recruiting | Knee Osteoarthritis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07308470) |
| September 24, 2025 | NCT07189585 | Inulin Supplementation for Reducing Inflammation and Knee Pain in Older Adults With Osteoarthritis | Yale University | Phase 2 | Not yet recruiting | Knee Osteoarthritis | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07189585) |
| April 4, 2025 | NCT06911359 | The Effect and Safety of Anti-inflammatories and Dextrose Prolotherapy Injections in Treating Knee Osteoarthritis | David Grant U.S. Air Force Medical Center | Phase 2 | Recruiting | Knee Osteoarthritis (OA) | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06911359) |
| March 19, 2025 | NCT06884865 | A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee | Pacira Pharmaceuticals, Inc | Phase 2 | Recruiting | Osteoarthritis (OA) of the Knee | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06884865) |
| March 18, 2025 | NCT06880926 | Antarctic Krill Oil for Knee Osteoarthritis Pain | Qilu Hospital of Shandong University | Phase 2 | Not yet recruiting | Osteoarthritis (OA) of the Knee, Osteoarthritis Knee Pain | 116 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06880926) |
| March 5, 2025 | NCT06859164 | Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis | University of Utah | Phase 2 | Recruiting | Knee Osteoarthritis, Knee Osteoarthritis (Knee OA), Knee Osteoarthritis (OA) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06859164) |
| February 25, 2025 | NCT06845553 | A Study to Assess the Efficacy and Safety of Vutiglabridin in Knee Osteoarthritis Patients | Glaceum | Phase 2 | Recruiting | Knee Osteoarthritis (Knee OA) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06845553) |
| February 19, 2025 | NCT06833749 | Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis | KeyBioscience AG | Phase 2 | Recruiting | Osteoarthritis in the Knee, Obesity | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06833749) |
| October 2, 2024 | NCT06623669 | A Mobile Intervention to Reduce Pain and Improve Health-III | Wake Forest University | Phase 2 | Recruiting | Chronic Pain, Osteoarthritis, Obesity and Overweight, Inactivity | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06623669) |
| September 20, 2024 | NCT06605963 | PPV-06 Vaccine in Inflammatory Knee Osteoarthritis | Peptinov SAS | Phase 2 | Not yet recruiting | Osteoarthritis, Knee | 204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06605963) |
| July 3, 2024 | NCT06485843 | An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint | Ageless Biotech, Inc. | Phase 2 | Recruiting | Osteoarthritis, Osteo Arthritis Knee | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06485843) |
| February 1, 2024 | NCT06237153 | Randomized Placebo Controlled Study of Triamcinolone Acetonide Extended Release Injection for Thumb (CMC) Osteoarthritis | Sponsor not shown (see the record) | Phase 2 | Recruiting | Carpometacarpal (CMC) Osteoarthritis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06237153) |
| January 31, 2024 | NCT06234631 | Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty | Sponsor not shown (see the record) | Phase 2 | Recruiting | Knee Replacement Surgery, Osteoarthritis, Knee | 380 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06234631) |
| October 23, 2023 | NCT06096259 | Preventing Injured Knees From osteoArthritis: Severity Outcomes | Brigham and Women's Hospital | Phase 2 | Recruiting | Osteoarthritis, Knee, Post-traumatic Osteoarthritis, ACL Tear | 512 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06096259) |
| August 14, 2023 | NCT05986292 | A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain | Eli Lilly and Company | Phase 2 | Recruiting | Osteoarthritis, Knee, Diabetic Neuropathic Pain, Chronic Low-back Pain | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05986292) |
| May 3, 2023 | NCT05839535 | Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA | Massachusetts General Hospital | Phase 2 | Recruiting | Knee Osteoarthritis | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05839535) |
| August 18, 2022 | NCT05507099 | Stem Cell Study in Osteoarthritis of the Knee and Hip Joints | Sponsor not shown (see the record) | Phase 2 | Recruiting | Osteoarthritis | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05507099) |
| December 23, 2021 | NCT05169229 | Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement. | University Hospital, Linkoeping | Phase 2 | Recruiting | Arthroplasty, Replacement, Hip, Osteoarthritis, Hip, Antibiotic Resistant Infection, Prosthetic Joint Infection | 1,100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05169229) |
| August 5, 2021 | NCT04992624 | Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee | Sponsor not shown (see the record) | Phase 2 | Recruiting | Osteoarthritis, Knee, Osteoarthritis of the Knee | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04992624) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| VivaTech International, Inc. | 3 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 2 |
| Endeavor Health | 1 |
| VA Office of Research and Development | 1 |
| Public Interest Science Center | 1 |
| Ageless Biotech, Inc. | 1 |
| Qilu Hospital of Shandong University | 1 |
| David Grant U.S. Air Force Medical Center | 1 |
| Wake Forest University | 1 |
| University Hospital, Linkoeping | 1 |
| Yale University | 1 |
| [Pacira Pharmaceuticals, Inc](https://specstream.ai/data/clinical-trials/company/pacira-pharmaceuticals-inc) | 1 |
| University of Utah | 1 |
| Peptinov SAS | 1 |
| University Hospital, Clermont-Ferrand | 1 |
| Glaceum | 1 |
| Pharos University in Alexandria | 1 |
| Sclnow Biotechnology Co., Ltd. | 1 |
| Enlivex Therapeutics Ltd. | 1 |
| Brigham and Women's Hospital | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
| KeyBioscience AG | 1 |
| Massachusetts General Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 19 |
| Puerto Rico | 2 |
| France | 2 |
| China | 2 |
| Denmark | 2 |
| Poland | 2 |
| Canada | 2 |
| Republic of the Congo | 1 |
| Sweden | 1 |
| South Korea | 1 |
| Egypt | 1 |
| Czechia | 1 |
| Hong Kong | 1 |
| Moldova | 1 |
| Romania | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Dumpster rental companies in the United States](https://specstream.ai/data/businesses/dumpster-rental-companies/united-states)
- [Manufacturing consultants in the United States](https://specstream.ai/data/businesses/manufacturing-consultants/united-states)
- [Sports medicine clinics in the United States](https://specstream.ai/data/businesses/sports-medicine-clinics/united-states)
- [Blinds and shades companies in the United States](https://specstream.ai/data/businesses/blinds-and-shades-companies/united-states)
- [General hospitals in the United States](https://specstream.ai/data/businesses/general-hospitals/united-states)
- [Pediatric neurology practices in the United States](https://specstream.ai/data/businesses/pediatric-neurology-practices/united-states)
